WORK to Save Lives Act
Sponsored By: Representative Watson Coleman, Bonnie [D-NJ-12]
Introduced
Summary
Workplace access to opioid overdose reversal medication would be expanded by directing OSHA to issue guidance for private employers and by requiring federal agencies to stock medication and offer annual voluntary training. Both the OSHA guidance and the mandatory federal regulations must be issued within 270 days.
Show full summary
- Private employers would get non-mandatory OSHA guidance on acquiring and maintaining opioid overdose reversal medication and on offering voluntary annual training. The U.S. Postal Service is explicitly excluded from that guidance.
- Every federal agency would be required to acquire and maintain opioid overdose reversal medication and offer voluntary annual training to employees under mandatory regulations.
- The Veterans Health Administration is expressly included among the federal entities covered by the mandatory rules.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Advice for employers on overdose medicine
If enacted, the Occupational Safety and Health Administration (OSHA) would issue nonbinding guidance to employers not later than 270 days after enactment. The guidance would explain how employers can acquire and maintain opioid overdose reversal medicine at worksites. It would also recommend offering voluntary annual training for employees on how to use the medicine. The guidance would follow the OSHA definition of "employer" but would not apply to the U.S. Postal Service.
Federal workplaces must carry overdose medicine
If enacted, OSHA would issue regulations not later than 270 days after enactment requiring each Federal agency to acquire and maintain opioid overdose reversal medicine. Federal agencies would also have to offer voluntary annual training to employees on how to use that medicine. The rule would apply to any agency or instrumentality of the Federal Government and would explicitly include the Veterans Health Administration.
Sponsors & CoSponsors
Sponsor
Watson Coleman, Bonnie [D-NJ-12]
NJ • D
Cosponsors
Rutherford
FL • R
Sponsored 2/10/2026
Rep. Tlaib, Rashida [D-MI-12]
MI • D
Sponsored 2/10/2026
Rep. McIver, LaMonica [D-NJ-10]
NJ • D
Sponsored 2/10/2026
Craig
MN • D
Sponsored 2/10/2026
Budzinski
IL • D
Sponsored 2/10/2026
Rep. Amo, Gabe [D-RI-1]
RI • D
Sponsored 2/10/2026
Davis (IL)
IL • D
Sponsored 2/10/2026
Rep. Thanedar, Shri [D-MI-13]
MI • D
Sponsored 2/10/2026
Rep. Goldman, Daniel S. [D-NY-10]
NY • D
Sponsored 2/10/2026
Rep. McClain Delaney, April [D-MD-6]
MD • D
Sponsored 2/10/2026
Carson
IN • D
Sponsored 2/10/2026
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 2/10/2026
Grijalva
AZ • D
Sponsored 2/10/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov